214 related articles for article (PubMed ID: 18465362)
1. Type 2 diabetes mellitus as risk factor for colorectal cancer.
Berster JM; Göke B
Arch Physiol Biochem; 2008 Feb; 114(1):84-98. PubMed ID: 18465362
[TBL] [Abstract][Full Text] [Related]
2. [Colorectal carcinoma screening in patients with type 2 diabetes mellitus].
Nagel JM; Göke B
Z Gastroenterol; 2006 Nov; 44(11):1153-65. PubMed ID: 17115358
[TBL] [Abstract][Full Text] [Related]
3. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea.
Chung YW; Han DS; Park KH; Eun CS; Yoo KS; Park CK
Dis Colon Rectum; 2008 May; 51(5):593-7. PubMed ID: 18219529
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and the risk for colorectal cancer.
Erbach M; Mehnert H; Schnell O
J Diabetes Complications; 2012; 26(1):50-5. PubMed ID: 22321219
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes and cancer: what is the connection?
Cannata D; Fierz Y; Vijayakumar A; LeRoith D
Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
[TBL] [Abstract][Full Text] [Related]
6. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.
Giouleme O; Diamantidis MD; Katsaros MG
World J Gastroenterol; 2011 Jan; 17(4):444-8. PubMed ID: 21274373
[TBL] [Abstract][Full Text] [Related]
7. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.
Yang YX; Hennessy S; Lewis JD
Gastroenterology; 2004 Oct; 127(4):1044-50. PubMed ID: 15480982
[TBL] [Abstract][Full Text] [Related]
8. Insulin therapy and cancer-specific mortality in patients with colorectal cancer and diabetes.
Kesikli SA; Unluturk U; Kilickap S
J Clin Oncol; 2012 May; 30(14):1729-30; author reply 1730-2. PubMed ID: 22493418
[No Abstract] [Full Text] [Related]
9. Assessment of the Risk of Colorectal Cancer in Patients with Diabetes Mellitus.
Agache A; Bîrligea A; Botea S; Cirstea M; Mihalache O; Mustăţea P
Chirurgia (Bucur); 2021 Oct; 116(5):620-626. PubMed ID: 34749858
[No Abstract] [Full Text] [Related]
10. Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications.
Yu GH; Li SF; Wei R; Jiang Z
J Diabetes Res; 2022; 2022():1747326. PubMed ID: 35296101
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes mellitus and the risk of colorectal cancer.
Yang YX; Hennessy S; Lewis JD
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):587-94. PubMed ID: 15952101
[TBL] [Abstract][Full Text] [Related]
12. Insulin therapy and colorectal adenomas in patients with diabetes mellitus.
Wong P; Weiner MG; Hwang WT; Yang YX
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1833-40. PubMed ID: 22879206
[TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
[TBL] [Abstract][Full Text] [Related]
14. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy.
Kanadiya MK; Gohel TD; Sanaka MR; Thota PN; Shubrook JH
J Diabetes Complications; 2013; 27(5):463-6. PubMed ID: 23755906
[TBL] [Abstract][Full Text] [Related]
15. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
16. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH
Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer in patients with diabetes - epidemiology, pathophysiology and applications for clinical practice.
Romanová A; Malinovská J; Lustigová M; Urbanová J; Brunerová L; Vejtasová V; Verma A; Duong TA; Šťovíček J; Brož J
Vnitr Lek; 2022; 68(2):116-122. PubMed ID: 36208926
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
Schiel R; Müller UA; Braun A; Stein G; Kath R
Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
20. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan.
Marugame T; Lee K; Eguchi H; Oda T; Shinchi K; Kono S
Cancer Causes Control; 2002 Dec; 13(10):917-21. PubMed ID: 12588087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
